For the month of April
2005
Commission File Number: 000-26498
NUR Macroprinters
Ltd.
(Translation of
registrant’s name into English)
12 Abba Hillel
Silver Street, Lod, Israel 71111
(Address of principal executive
offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________
On April 7, 2005, NUR Macroprinters Ltd. (the “Company”) issued a press announcing that it has received a notice from Nasdaq Listing Qualifications indicating that pursuant to the January 27, 2005 hearing before a Nasdaq Listing Qualification Panel, the panel has determined to postpone the delisting of the Company’s ordinary shares from trade on the Nasdaq SmallCap Market, and maintain the Company’s listing, subject to certain conditions as detailed in the press release.
The text of the press release is attached hereto as Exhibit 1.
The following document is attached hereto and incorporated herein by reference:
| Exhibit 1. | Press Release dated April 7, 2005 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NUR Macroprinters Ltd. BY: /S/ David Seligman —————————————— David Seligman Chief Financial Officer |
Date April 11, 2005
2
Exhibit Index
| Exhibit 1. | Press Release Dated April 7, 2005 |
3